Group 1 - The board of directors of Qinghai Spring Pharmaceutical Resources Technology Co., Ltd. held its 13th meeting of the 9th session on June 16, 2025, with all 7 directors present, and the meeting was deemed legally valid [2][4] - The board approved the proposal regarding the recognition of daily related transactions and the estimated daily related transactions for 2025, which was submitted after review by independent directors [3][30] - The proposal received 6 votes in favor, with no votes against or abstentions, and will be submitted to the shareholders' meeting for further approval [4][5] Group 2 - The company will hold its first temporary shareholders' meeting on July 3, 2025, to review the proposal regarding the recognition of daily related transactions [5][10] - The voting method for the shareholders' meeting will combine on-site voting and online voting through the Shanghai Stock Exchange network voting system [10][11] - The company has ensured that the daily related transactions are necessary for its normal production and operation, adhering to principles of fairness and transparency, and will not harm the interests of the company or minority investors [28][36] Group 3 - The actual amount of transactions with Yibin Tinghua Wine Industry Development Co., Ltd. in 2024 was 79 million yuan (including tax) [31] - The company has established a pricing policy for related transactions based on market prices and reasonable profit margins, ensuring that the transactions are conducted fairly [35][36] - The independent directors concluded that the related transactions are necessary for the company's operations and will not affect its independence or the interests of non-related shareholders [38][39]

Core Viewpoint - The company *ST Chuntian (600381.SH) has received regulatory measures from the China Securities Regulatory Commission (CSRC) for failing to disclose related party transactions and relationships with Yibin Tinghua Wine Industry Development Co., Ltd. [1][2] Group 1: Regulatory Actions - The CSRC's Qinghai Regulatory Bureau issued a decision on May 23, 2025, requiring *ST Chuntian to rectify its actions and issued warning letters to key executives including Zhang Xuefeng, Xiao Rong, Wang Lin, and Chen Ding [1][2] - The company was found to have made prepayments to Yibin Tinghua for product purchases without disclosing the related party relationship and transaction details [1] Group 2: Violations and Responsibilities - *ST Chuntian's actions violated multiple provisions of the "Management Measures for Information Disclosure of Listed Companies" [2] - Key executives, including the chairman and financial director, were held primarily responsible for the violations, with specific articles of the regulations cited against them [2]

Financial Performance - In 2024, the company achieved total revenue of 270 million yuan, a year-on-year increase of 26.36% [2][3] - The net profit attributable to shareholders was a loss of 199.77 million yuan, an improvement from a loss of 268.65 million yuan in the previous year [2][3] - The net profit excluding non-recurring items was a loss of 161.57 million yuan, compared to a loss of 243.67 million yuan in the previous year [2][3] - The net cash flow from operating activities was 80.97 million yuan, a significant increase of 238.56% year-on-year [2][3] Key Ratios - The basic earnings per share for 2024 was -0.34 yuan, with a weighted average return on equity of -17.26% [2][3] - The company's price-to-earnings ratio (TTM) is approximately -8.71 times, while the price-to-book ratio (LF) is about 1.68 times, and the price-to-sales ratio (TTM) is around 6.41 times [2][3] Asset and Liability Changes - As of the end of 2024, the company's net assets attributable to shareholders decreased by 18.38% compared to the previous year [3] - Inventory decreased by 41.44%, while cash and cash equivalents increased by 20.29% [51] - Contract liabilities increased by 106.8%, while lease liabilities decreased by 69.72% [54] Research and Development - The company invested 14.96 million yuan in research and development in 2024, a year-on-year increase of 28.54%, representing 5.54% of total revenue [61] Shareholder Structure - The largest shareholder, Tibet Rong'en Technology Co., Ltd., holds 32.13% of the shares, with significant pledges on their holdings [65] - New shareholders include Hu Zhenmin, Zhu Qiulian, Zhang Qian, and Ye Lingxiang, replacing previous shareholders [66]